Corrigendum to ‘A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption’ [Clin. Immunol. 142 (2012) 252–268]
Allard, Sabine D., De Keersmaecker, Brenda, de Goede, Anna L., Verschuren, Esther J., Koetsveld, Jeanette, Reedijk, Mariska L., Wylock, Carolien, De Bel, Annelies V., Vandeloo, Judith, Pistoor, Frank,Volume:
150
Language:
english
Journal:
Clinical Immunology
DOI:
10.1016/j.clim.2013.11.001
Date:
January, 2014
File:
PDF, 166 KB
english, 2014
File converter
More search results
More benefits 
